Malaria is a major public health threat causing almost 230 million infections and an estimated 409,000 deaths in 20191. The majority of deaths are in sub-Saharan Africa and are caused by the parasite Plasmodium falciparum, whose insect vector is Anopheles gambiae, the subject of this video demonstration. Although the numbers indicate a significant drop in annual death rate since the turn of the century (>300,000 fewer annual deaths), the promising decreases in disease rates observed from 2000 to 2015 are tapering, suggesting the need for new approaches to limiting disease transmission2. Among promising additional strategies for controlling and possibly eliminating malaria is targeting mosquito vector capacity using CRISPR/Cas9-based gene-editing and gene-drive3,4,5. Indeed, it is the targeting of the mosquito vector (through the expanded use of long-lasting insecticide-treated bed nets) that has had the greatest impact on reducing disease transmission6.
Female mosquitoes acquire Plasmodium gametocytes from an infected human during a blood meal. Following fertilization, maturation, midgut epithelium traversal, population expansion, and hemocoel navigation in their obligate mosquito hosts, hundreds to tens of thousands of Plasmodium sporozoites invade the mosquito SGs and fill the secretory cavities of the constituent secretory cells. Once inside the secretory cavities, the parasites have direct access to the salivary duct and are thus poised for transmission to a new vertebrate host upon the next blood meal. Because SGs are critical for the transmission of malaria-causing sporozoites to their human hosts, and laboratory studies suggest that SGs are not essential for blood-feeding, mosquito survival, or fecundity7,8,9, they represent an ideal target for transmission-blocking measures. Adult mosquito SGs form as an elaboration of "duct bud" remnants in the larval SGs that persist beyond early pupal SG histolysis10, making the larval SG an ideal target for interventions to limit adult-stage disease transmission.
Characterizing the larval stage of SG development can help develop not only a better understanding of its morphology and functional adaptations but can also aid in assessing new interventions that target this organ through gene editing of key SG regulators. Because all previous studies of larval salivary gland architecture predate immunostaining and modern imaging techniques10,11, we have developed a protocol for isolating and staining salivary glands with a variety of antibodies and cell markers12. This video demonstrates this approach to the extraction, fixation, and staining of larval SGs from Anopheles gambiae L4 larvae for confocal imaging.